Skip to main content

Prospective, randomized, double-blind study of safety and tolerability of intravesical resiniferatoxin (RTX) in interstitial cystitis (IC)

International Urogynecology Journal volume 16, pages 293–297 (2005)Cite this article

Abstract

Objective: To determine the safety and tolerability of intravesical resiniferatoxin (RTX) in interstitial cystitis (IC) patients. Materials and Methods: IC patients were instilled with 50 cc of test solution containing either placebo, 0.05 μM or 0.10 μM RTX in the bladder. Plasma concentration of RTX and its degradant resiniferonol 9-, 13-, 14-orthophenylacetate was measured. Immediate post-treatment blood sampling and cystoscopy were performed. Symptoms were evaluated before treatment, at 4- and at 12-week follow-ups, using VAS indicator for pain, voiding diary, and O’Leary’s IC symptom/problem indices. Results: Among 22 patients observed (ten in 0.10 μM RTX, eight in 0.05 μM RTX, and four in placebo groups), the most commonly reported adverse event was pain during instillation (80.0%, 87.5%, and 25.0%). No serious adverse events were reported. Conclusions: Use of intravesical RTX in IC patients is associated with important tolerability issues but safe at 0.10 μM and 0.05 μM.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Batra AK, Hanno PM, de Groat WC. Interstitial cystitis. AUA Update Series. Lesson 2, Volume XIX, 1999

  2. Sant GR (eds) (1997) Interstitial cystitis. Lippincott–Raven Publishers, Philadelphia

  3. Lazzeri M, Beneforti P, Spinelli M, Zanollo A, Barbagli G, Turini D (2000) Intravesical resiniferatoxin for the treatment of hypersensitive disorder: a randomized placebo controlled study. J Urol 164(3 Pt 1):676–679

    Google Scholar 

  4. Blok BF (2002) Central pathways controlling micturition and urinary continence. Urology 59(5 Suppl 1):13–17 (Review)

    Google Scholar 

  5. Chancellor MB, de Groat WC (1999) Intravesical capsaicin and resiniferatoxin therapy: spicing up the ways to treat the overactive bladder. J Urol 162(1):3–11 (Review)

    Google Scholar 

  6. Dodd LG, Tello J (1998) Cytologic examination of urine from patients with interstitial cystitis. Acta Cytol 42(4):923–927

    Google Scholar 

  7. Erickson DR, Belchis DA, Dabbs DJ (1997) Inflammatory cell types and clinical features of interstitial cystitis. J Urol 158(3 Pt 1):790–793

    Google Scholar 

  8. Elbadawi A (1997) Interstitial cystitis: a critique of current concepts with a new proposal for pathologic diagnosis and pathogenesis. Urology 49(5A Suppl):14–40 (Review)

    Google Scholar 

  9. Szallasi A, Conte B, Goso C, Blumberg PM, Manzini S (1993) Vanilloid receptors in the urinary bladder: regional distribution, localization on sensory nerves, and species-related differences. Naunyn Schmiedebergs Arch Pharmacol 347(6):624–629

    Google Scholar 

  10. Ishizuka O, Mattiasson A, Andersson KE (1995) Urodynamic effects of intravesical resiniferatoxin and capsaicin in conscious rats with and without outflow obstruction. J Urol 154(2 Pt 1):611–616

    Google Scholar 

  11. Craft RM, Carlisi VJ, Mattia A, Herman RM, Porreca F (1993) Behavioral characterization of the excitatory and desensitizing effects of intravesical capsaicin and resiniferatoxin in the rat. Pain 55(2):205–215

    Google Scholar 

  12. Szallasi A (2002) Vanilloid (capsaicin) receptors in health and disease. Am J Clin Pathol 118(1):110–121 (Review)

    Google Scholar 

  13. Szallasi A, Blumberg PM (1999) Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev 51(2):159–212 (Review)

    CAS  PubMed  Google Scholar 

  14. Silva C, Avelino A, Souto-Moura C, Cruz F (2001) A light- and electron-microscopic histopathological study of human bladder mucosa after intravesical resiniferatoxin application. BJU Int 88(4):355–360

    Google Scholar 

  15. Maggi CA, Santicioli P, Patacchini R, Geppetti P, Giuliani S, Astolfi GM, Baldi E, Parlani M, Theodorsson E, Fusco B et al (1988) Regional differences in the motor response to capsaicin in the guinea-pig urinary bladder: relative role of pre- and postjunctional factors related to neuropeptide-containing sensory nerves. Neuroscience 27(2):675–688

    Google Scholar 

  16. Amann R (1990) Desensitization of capsaicin-evoked neuropeptide release–influence of Ca2+ and temperature. Naunyn Schmiedebergs Arch Pharmacol 342(6):671–676

    Google Scholar 

  17. Winter J, Dray A, Wood JN, Yeats JC, Bevan S (1990) Cellular mechanism of action of resiniferatoxin: a potent sensory neuron excitotoxin. Brain Res 520(1–2):131–140

    Google Scholar 

  18. Craft RM, Cohen SM, Porreca F (1995) Long-lasting desensitization of bladder afferents following intravesical resiniferatoxin and capsaicin in the rat. Pain 61(2):317–323

    Google Scholar 

  19. Cruz F (1998) Desensitization of bladder sensory fibers by intravesical capsaicin or capsaicin analogs. A new strategy for treatment of urge incontinence in patients with spinal detrusor hyperreflexia or bladder hypersensitivity disorders. Int Urogynecol J Pelvic Floor Dysfunct 9(4):214–220 (Review)

    Google Scholar 

  20. Fowler CJ (2002) Bladder afferents and their role in the overactive bladder. Urology 59(5 Suppl 1):37–42 (Review)

    Google Scholar 

  21. Avelino A, Cruz F, Coimbra A (1999) Intravesical resiniferatoxin desensitizes rat bladder sensory fibres without causing intense noxious excitation. A c-fos study. Eur J Pharmacol 378(1):17–22

    Google Scholar 

  22. Giannantoni A, Di Stasi SM, Stephen RL, Navarra P, Scivoletto G, Mearini E, Porena M (2002) Intravesical capsaicin versus resiniferatoxin in patients with detrusor hyperreflexia: a prospective randomized study. J Urol 167(4):1710–1714

    Article  CAS  PubMed  Google Scholar 

  23. de Seze M, Wiart L, Joseph PA, Dosque JP, Mazaux JM, Barat M (1998) Capsaicin and neurogenic detrusor hyperreflexia: a double-blind placebo-controlled study in 20 patients with spinal cord lesions. Neurourol Urodyn 17(5):513–523

    Article  PubMed  Google Scholar 

  24. Silva C, Rio ME, Cruz F (2000) Desensitization of bladder sensory fibers by intravesical resiniferatoxin, a capsaicin analog: long-term results for the treatment of detrusor hyperreflexia. Eur Urol 38(4):444–452

    Google Scholar 

  25. Lazzeri M, Spinelli M, Beneforti P, Zanollo A, Turini D (1998) Intravesical resiniferatoxin for the treatment of detrusor hyperreflexia refractory to capsaicin in patients with chronic spinal cord diseases. Scand J Urol Nephrol 32(5):331–334

    Google Scholar 

Download references

Author information

Affiliations

  1. Centre Hospitalier Universitaire de Sherbrooke, Université de Sherbrooke, Service d’urologie 3001, 12e ave Nord, Fleurimont (Qc), J1H 5N4, Canada

    Tony YH Chen, Michel Camel, Yves Ponsot & Le Mai Tu

  2. Jewish General Hospital, McGill University, Montreal, Canada

    Jacques Corcos

Authors
  1. Tony YH Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jacques Corcos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michel Camel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yves Ponsot
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Le Mai Tu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tony YH Chen.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Chen, T.Y., Corcos, J., Camel, M. et al. Prospective, randomized, double-blind study of safety and tolerability of intravesical resiniferatoxin (RTX) in interstitial cystitis (IC). Int Urogynecol J 16, 293–297 (2005). https://doi.org/10.1007/s00192-005-1307-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00192-005-1307-4

Keywords

  • Interstitial cystitis
  • Resiniferatoxin (RTX)
  • Intravesical treatment